ASA Issues Emergency State Guidance on Medical Cannabis Patient Protections

State Officials Receive Federal-Enforcement Response Framework

ASA's guidance memorandum addresses five categories of state authority: regulatory enforcement, patient registry protections, health department protocols, attorney general litigation strategy, and legislative emergency measures. The document was distributed to state officials in all 38 medical cannabis jurisdictions plus the District of Columbia.

The timing follows escalating rhetoric from the Acting Attorney General regarding enforcement discretion under the Controlled Substances Act. State medical cannabis programs operate in conflict with federal Schedule I classification on a strict reading of the CSA. That creates exposure for patients, caregivers, and state-licensed operators.

ASA's memorandum doesn't cite specific enforcement threats by name but references "recent statements from DOJ leadership" as the triggering event. The organization has been coordinating with state officials since early June on contingency planning.

Guidance Prioritizes Patient Registry Confidentiality

The memorandum instructs health departments to invoke state medical privacy statutes and refuse federal requests for patient registry data without a court order meeting heightened scrutiny standards. Thirty-two states maintain closed medical cannabis registries. Those registries are subject to HIPAA-equivalent state confidentiality laws.

Key recommendations for health departments include:

• Immediate legal review of registry data-sharing agreements with federal agencies
• Suspension of voluntary information sharing pending legal counsel
• Preparation of litigation defense for compelled disclosure requests
• Patient notification protocols if registry data is compromised

State medical privacy laws in California, Oregon, and Massachusetts have withstood federal preemption challenges in prior contexts, the guidance notes, though they haven't been tested specifically for cannabis registries.

Attorneys General Advised on Litigation Posture

ASA recommends state attorneys general prepare declaratory judgment actions asserting Tenth Amendment limits on federal commandeering of state regulatory infrastructure. The memorandum cites Printz v. United States (1997) and Murphy v. NCAA (2018) as controlling precedent for state sovereignty defenses.

The litigation strategy focuses on three arguments:

1. Federal government can't compel state officials to enforce federal cannabis prohibition
2. State medical cannabis laws don't affirmatively authorize conduct violating the CSA, only decline to impose state penalties
3. Patients acting in compliance with state law retain reliance-interest protections under due process

ASA identifies six state attorneys general—California, Colorado, Illinois, Massachusetts, New York, and Washington—as having existing legal teams with cannabis-litigation experience. Coordinated multi-state litigation could establish uniform precedent, the guidance suggests.

Legislative Emergency Measures Outlined

The memorandum provides model statutory language for emergency legislative sessions, including patient-defense funds, state-employee indemnification, and regulatory firewall provisions. Twelve states have constitutional mechanisms for emergency legislative sessions callable by the governor without full legislative consent.

Proposed statutory protections include appropriations for legal defense of patients facing federal prosecution, indemnification of state cannabis regulators against personal liability, and severability clauses isolating medical programs from adult-use provisions if federal enforcement targets recreational markets.

ASA's guidance stops short of recommending state nullification statutes. Such measures have been struck down in other contexts. Instead, the framework emphasizes procedural protections and resource allocation to support patients in federal court.

For full background on state medical cannabis frameworks and federal enforcement history, see the CannIntel topic hub on medical cannabis patient protections.

The next signal: whether any state attorney general files a preemptive declaratory judgment action before the end of June. ASA's guidance suggests such filings would establish favorable venue and framing before DOJ moves.